التداخل بين دروسبيرينون وإيثينيل إستراديول ونابروكسين وإيزوميبرازول

Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS.

In vitro , EE is a reversible inhibitor of CYP2C19, CYP1A1 and CYP1A2 as well as a mechanism-based inhibitor of CYP3A4/5, CYP2C8, and CYP2J2.

These results demonstrate that DRSP did not inhibit CYP2C19 and CYP3A4 in vivo .